AU2893595A - Use of muramyl peptide compounds - Google Patents

Use of muramyl peptide compounds

Info

Publication number
AU2893595A
AU2893595A AU28935/95A AU2893595A AU2893595A AU 2893595 A AU2893595 A AU 2893595A AU 28935/95 A AU28935/95 A AU 28935/95A AU 2893595 A AU2893595 A AU 2893595A AU 2893595 A AU2893595 A AU 2893595A
Authority
AU
Australia
Prior art keywords
peptide compounds
muramyl peptide
muramyl
compounds
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28935/95A
Other languages
English (en)
Inventor
Philip Ledger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peptech UK Ltd
Original Assignee
Peptech UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptech UK Ltd filed Critical Peptech UK Ltd
Publication of AU2893595A publication Critical patent/AU2893595A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU28935/95A 1994-07-11 1995-07-10 Use of muramyl peptide compounds Abandoned AU2893595A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9413935A GB9413935D0 (en) 1994-07-11 1994-07-11 Use of maramyl peptide compounds
GB9413935 1994-07-11
PCT/GB1995/001619 WO1996001645A1 (en) 1994-07-11 1995-07-10 Use of muramyl peptide compounds
CN95194573A CN1155245A (zh) 1994-07-11 1995-07-10 胞壁酰肽化合物的应用

Publications (1)

Publication Number Publication Date
AU2893595A true AU2893595A (en) 1996-02-09

Family

ID=25743816

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28935/95A Abandoned AU2893595A (en) 1994-07-11 1995-07-10 Use of muramyl peptide compounds

Country Status (13)

Country Link
EP (1) EP0768888A1 (sk)
JP (1) JPH10505580A (sk)
CN (1) CN1155245A (sk)
AU (1) AU2893595A (sk)
BG (1) BG101126A (sk)
CA (1) CA2194678A1 (sk)
CZ (1) CZ4797A3 (sk)
GB (1) GB9413935D0 (sk)
HU (1) HUT77290A (sk)
IL (1) IL114542A0 (sk)
SK (1) SK2697A3 (sk)
WO (1) WO1996001645A1 (sk)
ZA (1) ZA955763B (sk)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1038532A4 (en) * 1997-04-11 2003-08-13 Oleg Vitallievich Kaljuzhin IMMUNO MODULATOR AND PHARMACEUTICAL COMPOSITIONS WITH ANTITUM PROPERTIES, AND A FOOD ADDITIVE
GB9710351D0 (en) * 1997-05-20 1997-07-16 Scotia Holdings Plc Glucosamine fatty acids
WO1999062537A1 (en) * 1998-06-04 1999-12-09 The Rockefeller University Methods and agents for modulating the immune response and inflammation involving monocyte and dendritic cell membrane proteins
DE10106852A1 (de) * 2001-02-14 2002-09-05 T Luger Entzündungshemmende Verbindungen
FR2899466B1 (fr) * 2006-04-07 2008-09-26 Oreal Utilisation de compose c-glycoside agent activateur et regulateur de l'immunite cutanee
US20120156137A1 (en) 2006-10-20 2012-06-21 Soo-Youl Kim Composition for treatment of atopic dermatitis comprising glucosamine and derivatives thereof and a method for treatment of atopic dermatitis using them
US8603978B2 (en) * 2006-12-01 2013-12-10 The United States of America, as represented by the Secretary, Department of Health and Humand Services Use of muramyl dipeptide (MDP) for treating inflammation
FR2933984B1 (fr) * 2008-07-15 2013-01-04 Univ Bourgogne D,d muramyldipeptide,composes derives et utilisation pour le traitement des plaques atheromateuses
US10610564B2 (en) 2015-02-26 2020-04-07 Stc.Unm IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
ES2930246T3 (es) 2015-12-10 2022-12-09 Bharat Biotech Int Ltd Nuevo compuesto derivado del péptido muramilo, síntesis y utilizaciones del mismo
CN108883080B (zh) * 2015-12-15 2021-12-21 巴拉特生物技术国际有限公司 胞壁酰肽衍生物化合物、其合成及其用途
MX2023011004A (es) 2021-03-19 2024-01-08 Trained Therapeutix Discovery Inc Compuestos para regular la inmunidad entrenada y métodos para usarlos.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4357322A (en) * 1980-07-29 1982-11-02 Syntex (U.S.A.) Inc. Method of preventing, reducing or inhibiting inflammation
US4698330A (en) * 1983-06-27 1987-10-06 President & Fellows Of Harvard College Somnogenic compositions and method of use
HU205147B (en) * 1989-06-29 1992-03-30 Sandoz Ag Process for producing muramyl dipeptide derivative and pharmaceutical compostions comprising same
US5506204A (en) * 1991-11-19 1996-04-09 Peptech (Uk) Limited Muramyl compounds for treatment of septic shock
GB9204354D0 (en) * 1992-02-28 1992-04-08 Biokine Tech Ltd Compounds for medicinal use
GB9320820D0 (en) * 1993-10-08 1993-12-01 Biokine Tech Ltd Compounds for medicinal use
GB9326518D0 (en) * 1993-12-29 1994-03-02 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
GB9413935D0 (en) 1994-08-31
HUT77290A (hu) 1998-03-30
JPH10505580A (ja) 1998-06-02
IL114542A0 (en) 1995-11-27
CZ4797A3 (en) 1997-07-16
CA2194678A1 (en) 1996-01-25
EP0768888A1 (en) 1997-04-23
ZA955763B (en) 1997-01-13
CN1155245A (zh) 1997-07-23
HU9700071D0 (en) 1997-02-28
BG101126A (en) 1997-09-30
SK2697A3 (en) 1997-08-06
WO1996001645A1 (en) 1996-01-25

Similar Documents

Publication Publication Date Title
AU2805195A (en) Therapeutic compounds
GB9526560D0 (en) Use of 2-Amino-Heterocycles
IL113248A0 (en) Use of alpha - 1c specific compounds
AU4953796A (en) Dipeptide compounds having ahpba structure
AU2893595A (en) Use of muramyl peptide compounds
AU2131195A (en) Prophenins - antibiotic peptides
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU4399396A (en) Compounds
AU3527495A (en) Use of muramyl peptide compounds
GB9506372D0 (en) New peptide compounds
AU3856995A (en) UCF116 Compounds
AUPM489194A0 (en) Peptides
AU4292496A (en) Improved mutable composition
ZA978027B (en) The use of muramyl peptides
AU1798100A (en) Use of peptide
NZ295530A (en) Preparation of 1-halo-3-trialkylsilanyl-benzenes
AU1824195A (en) Oral synthetic peptide preparation
AU2301295A (en) Guanidino-substituted compounds
AU6476398A (en) Novel peptides
AU3040797A (en) Preparation of alpha-fluoroketones
AU3705597A (en) Preparation of aminomethyl-phenylimidazoles
GB9422764D0 (en) Use of compound
AUPM594094A0 (en) Analysis of iridodial
GB9418295D0 (en) Preparation of indoloquinone compounds
AUPO007296A0 (en) New peptide compounds